Item(by='hirenj', descendants=None, kids=None, score=None, time=1608373853, title=None, item_type='comment', url=None, parent=25470628, text='Yes, and no. The principle is there, but it is important to understand that each cell type is essentially a specialist factory to produce proteins, and the drug <i>may</i> be produced best when you get exactly the right factory to produce the protein (Iâ€™m thinking about PTMs). If your body is flooded by inferior product from the wrong factories, the effect of the superior product may be inhibited of diluted.<p>That said, I can imagine once we figure out how to deliver the mRNA to precisely the right targets, this would be a lot easier (eg engineering receptor ligands onto the mRNA lipid delivery particles).')